Previously treated cases tested for RR-/MDR-TB (%) in Equatorial Guinea
Equatorial Guinea: Previously treated cases tested for RR-/MDR-TB was 88.0% in 2024. ◆ Volatile
Latest (2024)
88.0%
Change on year
up 39.7%
World rank
90th
of 180 countries
All-time high
100.0%
in 2017
All-time low
0.0%
in 2008
Years of data
13
2008–2024
Previously treated cases tested for RR-/MDR-TB in Equatorial Guinea, 2008–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Equatorial Guinea stood at 88.0%.
The figure is up 39.7% on the previous year and up 1,500.0% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Equatorial Guinea peaked at 100.0% in 2017 and was at its lowest, 0.0%, in 2008.
Equatorial Guinea ranks 90th of 180 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Equatorial Guinea, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2010 | 0.0% | — |
| 2014 | 5.5% | — |
| 2015 | 30.0% | +445.5% |
| 2016 | 64.0% | +113.3% |
| 2017 | 100.0% | +56.2% |
| 2018 | 100.0% | +0.0% |
| 2019 | 22.0% | -78.0% |
| 2020 | 17.0% | -22.7% |
| 2021 | 67.0% | +294.1% |
| 2022 | 68.0% | +1.5% |
| 2023 | 63.0% | -7.4% |
| 2024 | 88.0% | +39.7% |
Equatorial Guinea compared with similar countries
- Equatorial Guinea's 88.0% is below the median for upper middle income countries, which is 92.0%, 96% of the median. (52 countries reporting)
- Equatorial Guinea's 88.0% is below the median for Sub-Saharan Africa, which is 91.5%, 96% of the median. (46 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 1 |
| 2010s | 45.9% | 0.0% | 100.0% | 7 |
| 2020s | 60.6% | 17.0% | 88.0% | 5 |
Countries ranked near Equatorial Guinea
More health data for Equatorial Guinea
- Un projection of annual infant deaths, annual growth rate -1.4 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.06 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 863.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 843 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 5 (2025)
- Population ages 00-04, female, annual growth rate 1.5 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0663 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.66 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Equatorial Guinea?
- Previously treated cases tested for rr-/mdr-tb in Equatorial Guinea was 88.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Equatorial Guinea?
- The highest recorded value was 100.0% in 2017.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Equatorial Guinea?
- The lowest recorded value was 0.0% in 2008.
- How does Equatorial Guinea rank for previously treated cases tested for rr-/mdr-tb?
- Equatorial Guinea ranks 90th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Equatorial Guinea?
- Over the last ten years it is up 1,500.0%. The long-run trend across the full record is volatile.
- Where does this Equatorial Guinea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 13 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).